Introduction: We aimed to analyze the frequency, clinical characteristics, medical treatment options and final functional status of Guillain-Barré syndrome (GBS) and its variants in a population from a tertiary hospital setting. Methods: All medical records of patients with acute inflammatory polyneuropathy between the years of 1998-2013 were retrospectively screened. Demographic, clinical and laboratory information, treatment options and the rate of recovery of the patients were gathered. Results: A total of 183 patients met the study criteria. Subtypes were typical demyelinating form (n=102, 79.1%), acute motor sensory axonal variant (n=11, 8.5%), acute motor axonal variant (n=10, 7.8%), Miller-Fisher syndrome (n=5, 3.9%), and pure sensory subtype (n=1, 0.8%). Remaining patients had the diagnosis of acute-onset chronic inflammatory demyelinating polynuropathy. The data of treatment option were available for 70 patients. Most of the patients received intravenous immunoglobulin (IVIg) treatment or the combination of IVIg and methylprednisolone. One patient died, there was no improvement in eight patients and rest showed improvement with varying degrees. Conclusions: We did not observe major change of recovery between different treatment options, however, most of the patients using methylprednisolone required IVIg because of inadequate response.
Re cei ved/Ge lifl Ta ri hi: 22.12.2013 Ac cep ted/Ka bul Ta ri hi: 04.03.2014 Itchiness is the desire for mechanical irritation of the skin and it may result from various dermatological and sometimes neurological diseases. Neurological causes for itch are relatively unknown and frequently overlooked. Here, we report a case of possible acute inflamatory polyradiculopathy who had facial pruritus and diplopia as the initial symptoms. Diagnosis of our patient was delayed because initial diplopia and pruritus complaints were considered as nonspecific and unrelated to the nervous system. We suggest that pruritus may be a remarkable neurological finding especially when it is accompanied by other neurological symptoms. (Turkish Journal of Neurology 2015; 21:74-6)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.